SMS Lifesciences India Bilan de santé
Santé financière contrôle des critères 4/6
SMS Lifesciences India possède un total de capitaux propres de ₹2.0B et une dette totale de ₹894.9M, ce qui porte son ratio d'endettement à 44%. Son actif total et son passif total sont ₹3.9B et de ₹1.9B. L'EBIT de SMS Lifesciences India est ₹307.4M ce qui fait que son ratio de couverture des intérêts 3.3. Elle dispose de liquidités et de placements à court terme de ₹11.9M.
Informations clés
44.0%
Ratio d'endettement
₹894.94m
Dette
| Ratio de couverture des intérêts | 3.3x |
| Argent liquide | ₹11.92m |
| Fonds propres | ₹2.03b |
| Total du passif | ₹1.88b |
| Total des actifs | ₹3.91b |
Mises à jour récentes de la santé financière
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Recent updates
Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive
Nov 14Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified
Aug 27Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 13SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Analyse de la situation financière
Passif à court terme: Les actifs à court terme de SMSLIFE ( ₹1.5B ) dépassent ses passifs à court terme ( ₹1.4B ).
Passif à long terme: Les actifs à court terme de SMSLIFE ( ₹1.5B ) dépassent ses passifs à long terme ( ₹441.0M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de SMSLIFE ( 43.4% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de SMSLIFE est passé de 42% à 44% au cours des 5 dernières années.
Couverture de la dette: La dette de SMSLIFE est bien couverte par le flux de trésorerie opérationnel ( 37.4% ).
Couverture des intérêts: Les paiements d'intérêts de SMSLIFE sur sa dette sont bien couverts par l'EBIT ( 3.3 x couverture).